Composition
| Ingredient |
Amount |
Unit |
| Each ml of BroncoZand® contains : |
|
|
| bromhexine hydrochloride |
10 |
mg |
Mechanism of action
Bromhexine is a benzylamine compound with mucolytic and expectorant properties. By increasing serous secretion in the bronchial glands, increasing secretion volume, and reducing mucus viscosity, it helps liquefy secretions and facilitate their clearance from the respiratory tract.
Bromhexine stimulates lysosomal enzyme activity and increases the hydrolysis and degradation of glycoproteins and acidic mucopolysaccharides in secretions, altering mucus structure and reducing its viscosity. It also supports respiratory clearance by increasing tracheobronchial ciliary activity and improving mucociliary transport.
Bromhexine may also increase the levels of certain proteins and immunoglobulins, including IgA and IgG, in respiratory secretions. Increased bronchial secretions and reduced mucus viscosity facilitate more effective secretion clearance and improve respiratory clearance function.
Target species
Livestock and poultry
Indications
BroncoZand® is used as supportive therapy for respiratory diseases accompanied by increased or accumulated secretions, including infectious bronchitis, chronic respiratory disease (CRD), infectious laryngotracheitis, and infectious coryza in chickens; infectious sinusitis in turkeys; and pneumonia, bronchopneumonia, rhinitis, and cough in calves, foals, lambs, and kids.
Packaging
1 liter polyethylene bottles
Storage Conditions
Store below 25°C, protected from direct light, in the original packaging. After opening, keep the container cap tightly closed. Protect from freezing.